ENTRY       D10395                      Drug
NAME        Nesvacumab (USAN/INN)
FORMULA     C6440H9966N1722O2008S38
EXACT_MASS  144770.005
MOL_WEIGHT  144858.8406
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYDIHWVRQA TGKGLEWVSA IGPAGDTYYP
            GSVKGRFTIS RENAKNSLYL QMNSLRAGDT AVYYCARGLI TFGGLIAPFD YWGQGTLVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPELL
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR
            DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS STYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ HYDNSQTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H95, H149-H205, H225-L214, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'95, H'149-H'205, H'225-L'214, H'266-H'326, H'372-H'430, L23-L89, L134-L194, L'23-L'89, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Angiogenesis inhibitor
  TYPE      Monoclonal antibody
TARGET      ANGPT2 [HSA:285] [KO:K05466]
  PATHWAY   hsa04066(285)  HIF-1 signaling pathway
            hsa04151(285)  PI3K-Akt signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                ANGPT2
                 D10395  Nesvacumab (USAN/INN)
DBLINKS     CAS: 1296818-77-3
            PubChem: 172232488
///
